EBV-induced lymphoproliferative disease due to CD70 deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:538958OMIM:618261D82.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

EBV-induced lymphoproliferative disease due to CD70 deficiency is a rare inherited immune system disorder. CD70 is a protein that helps immune cells — especially T cells and natural killer (NK) cells — respond properly to infections. When the CD70 gene is not working correctly, the immune system cannot control a common virus called Epstein-Barr virus (EBV), also known as the virus that causes mononucleosis or 'mono.' In healthy people, EBV infects most individuals in childhood or early adulthood and then stays dormant, kept in check by the immune system. In people with CD70 deficiency, the immune system fails to control EBV, which can trigger abnormal and dangerous overgrowth of white blood cells called lymphocytes. This overgrowth is called lymphoproliferative disease. The condition can cause swollen lymph nodes, an enlarged spleen and liver, fever, and fatigue. In more serious cases, it can lead to lymphoma (a type of blood cancer), hemophagocytic lymphohistiocytosis (HLH, a life-threatening immune overreaction), or common variable immunodeficiency (CVID), which means the immune system is generally weakened. This disease is also sometimes referred to as CD70 deficiency-associated EBV lymphoproliferative disease or simply CD70 deficiency. Treatment depends on how the disease presents. Some patients need antiviral therapy, immunosuppressive drugs, or chemotherapy for lymphoma. The only potentially curative treatment currently available is a bone marrow transplant (also called hematopoietic stem cell transplantation or HSCT), which replaces the faulty immune system with a healthy one. Early diagnosis is very important because catching the disease before serious complications develop can greatly improve outcomes.

Also known as:

Key symptoms:

Swollen lymph nodes (lumps in the neck, armpits, or groin)Enlarged spleen (splenomegaly)Enlarged liver (hepatomegaly)Persistent or recurrent feverExtreme tiredness and fatigueFrequent or severe infectionsDevelopment of lymphoma (blood cancer involving lymph cells)Hemophagocytic lymphohistiocytosis (HLH) — a dangerous immune overreaction causing high fever, organ damageLow levels of antibodies in the blood (hypogammaglobulinemia)Recurrent respiratory infectionsWeight lossNight sweats

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for EBV-induced lymphoproliferative disease due to CD70 deficiency.

View clinical trials →

No actively recruiting trials found for EBV-induced lymphoproliferative disease due to CD70 deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the EBV-induced lymphoproliferative disease due to CD70 deficiency community →

No specialists are currently listed for EBV-induced lymphoproliferative disease due to CD70 deficiency.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to EBV-induced lymphoproliferative disease due to CD70 deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open EBV-induced lymphoproliferative disease due to CD70 deficiencyForum →

No community posts yet. Be the first to share your experience with EBV-induced lymphoproliferative disease due to CD70 deficiency.

Start the conversation →

Latest news about EBV-induced lymphoproliferative disease due to CD70 deficiency

No recent news articles for EBV-induced lymphoproliferative disease due to CD70 deficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Should my child be tested for EBV now, and how often should EBV levels be monitored?,Is my child a candidate for a bone marrow transplant, and when would be the best time to do it?,Does my child need IVIG infusions, and how will we know if they are working?,What signs of HLH or lymphoma should I watch for at home, and when should I go to the emergency room?,Should other family members — siblings or parents — be tested for this condition?,Are there any clinical trials or research studies that my child might be eligible for?,What vaccinations are safe for my child, and are there any that must be avoided?

Common questions about EBV-induced lymphoproliferative disease due to CD70 deficiency

What is EBV-induced lymphoproliferative disease due to CD70 deficiency?

EBV-induced lymphoproliferative disease due to CD70 deficiency is a rare inherited immune system disorder. CD70 is a protein that helps immune cells — especially T cells and natural killer (NK) cells — respond properly to infections. When the CD70 gene is not working correctly, the immune system cannot control a common virus called Epstein-Barr virus (EBV), also known as the virus that causes mononucleosis or 'mono.' In healthy people, EBV infects most individuals in childhood or early adulthood and then stays dormant, kept in check by the immune system. In people with CD70 deficiency, the imm

How is EBV-induced lymphoproliferative disease due to CD70 deficiency inherited?

EBV-induced lymphoproliferative disease due to CD70 deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does EBV-induced lymphoproliferative disease due to CD70 deficiency typically begin?

Typical onset of EBV-induced lymphoproliferative disease due to CD70 deficiency is childhood. Age of onset can vary across affected individuals.